Literature DB >> 24648553

Trichosporon mycotoxinivorans infection in patients with cystic fibrosis.

Avani V Shah1, Susanna A McColley1, Diane Weil2, Xiaotian Zheng3.   

Abstract

We describe the clinical course of four patients who had Trichosporon mycotoxinivorans recovered from multiple sputum cultures over time with various clinical consequences but no fatalities. We also report successful rapid identification of this organism using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24648553      PMCID： PMC4042814          DOI： 10.1128/JCM.03309-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.

Authors:  J L Burns; J M Van Dalfsen; R M Shawar; K L Otto; R L Garber; J M Quan; A B Montgomery; G M Albers; B W Ramsey; A L Smith
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

2.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species.

Authors:  Lindsay G Stevenson; Steven K Drake; Yvonne R Shea; Adrian M Zelazny; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

3.  Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins.

Authors:  Orsolya Molnar; Gerd Schatzmayr; Elisabeth Fuchs; Hansjoerg Prillinger
Journal:  Syst Appl Microbiol       Date:  2004-11       Impact factor: 4.022

Review 4.  Current knowledge of Trichosporon spp. and Trichosporonosis.

Authors:  Arnaldo L Colombo; Ana Carolina B Padovan; Guilherme M Chaves
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  O Bader; M Weig; L Taverne-Ghadwal; R Lugert; U Gross; M Kuhns
Journal:  Clin Microbiol Infect       Date:  2010-12-03       Impact factor: 8.067

6.  Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient.

Authors:  Sandrine Hirschi; Valérie Letscher-Bru; Julien Pottecher; Béatrice Lannes; Mi Young Jeung; Tristan Degot; Nicola Santelmo; Alina Marcela Sabou; Raoul Herbrecht; Romain Kessler
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

8.  Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.

Authors:  Patrick W Hickey; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Brian L Wickes; Howard J Schmidt; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

9.  The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort.

Authors:  Carolin Kröner; Matthias Kappler; Ann-Christin Grimmelt; Gudrun Laniado; Benjamin Würstl; Matthias Griese
Journal:  BMC Pulm Med       Date:  2013-11-01       Impact factor: 3.317
  9 in total
  8 in total

1.  Evaluating and Improving Vitek MS for Identification of Clinically Relevant Species of Trichosporon and the Closely Related Genera Cutaneotrichosporon and Apiotrichum.

Authors:  João N de Almeida; Viviane M Favero Gimenes; Elaine C Francisco; Lumena P Machado Siqueira; Renato K Gonçalves de Almeida; Juliette Guitard; Christophe Hennequin; Arnaldo L Colombo; Gil Benard; Flavia Rossi
Journal:  J Clin Microbiol       Date:  2017-05-24       Impact factor: 5.948

Review 2.  Progress and challenges in fungal lung disease in cystic fibrosis.

Authors:  Gina Hong
Journal:  Curr Opin Pulm Med       Date:  2022-09-19       Impact factor: 2.868

Review 3.  Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.

Authors:  Carsten Schwarz; Dominik Hartl; Olaf Eickmeier; Andreas Hector; Christian Benden; Isabelle Durieu; Amparo Sole; Silvia Gartner; Carlos E Milla; Peter James Barry
Journal:  Mycopathologia       Date:  2017-07-31       Impact factor: 2.574

4.  A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method.

Authors:  Daniel Goldenberger; Vladimira Hinić; Spasenija Savic Prince; Michael Tamm; Anna-Maria Balestra; Doris Hohler; Reno Frei
Journal:  BMC Infect Dis       Date:  2016-10-25       Impact factor: 3.090

5.  Emergence of Trichosporon mycotoxinivorans (Apiotrichum mycotoxinivorans) invasive infections in Latin America.

Authors:  João Nobrega de Almeida; Elaine Cristina Francisco; Maria Goreth M de Andrade Barberino; Luiz Vicente Ribeiro F da Silva; Oriana M Brandão; Arnaldo Lopes Colombo; Ana Carolina Barbosa Padovan
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-10       Impact factor: 2.743

6.  Organization of Patient Management and Fungal Epidemiology in Cystic Fibrosis.

Authors:  Carsten Schwarz; Jean-Philippe Bouchara; Walter Buzina; Vanda Chrenkova; Hanna Dmeńska; Elia Gomez Garcia de la Pedrosa; Rafael Cantón; Ersilia Fiscarelli; Yohann Le Govic; Nahid Kondori; Tadeja Matos; Ewa Romanowska; Stefan Ziesing; Ludwig Sedlacek
Journal:  Mycopathologia       Date:  2017-11-03       Impact factor: 2.574

7.  Complete Genome Sequencing and Comparative Analysis of the Clinically-Derived Apiotrichum mycotoxinivorans Strain GMU1709.

Authors:  Liang Peng; Chen-Fei Liu; Hong Wu; Hai Jin; Xiao-Yan Deng; Li-Ting Zeng; Yi Xiao; Cong Deng; Zhi-Kai Yang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-04       Impact factor: 5.293

8.  Bronchial Artery-Pulmonary Artery Shunt by Apiotrichum mycotoxinivorans Infection in a Recurrent Hemoptysis Case.

Authors:  Yu Pang; Diefei Hu; Yiwu Dang; Siming Huang; Lanhui Qin; Meng Li
Journal:  Infect Drug Resist       Date:  2022-08-18       Impact factor: 4.177
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.